Mario Grisanti

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

Ji Li, Ildiko Sarosi, Russell C. Cattley et al. · Bone · 2006 · 429 citations

Mechanobiology, Sclerostin, Dkk1-mediated Inhibition +8

Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL

Paul J. Kostenuik, Hung Q. Nguyen, James McCabe et al. · Journal of Bone and Mineral Research · 2008 · 428 citations

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair

Mónica Florio, Kannan Gunasekaran, Marina Stolina et al. · Nature Communications · 2016 · 248 citations · Full text

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

Xiaodong Li, Kelly Warmington, Qing‐Tian Niu et al. · Journal of Bone and Mineral Research · 2010 · 233 citations

Sclerostin, Immunology, Orthopaedic Surgery +21

Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression

Gisela Ruiz Heiland, Karin Zwerina, Wolfgang Baum et al. · Annals of the Rheumatic Diseases · 2010 · 203 citations